318.49
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $318.49, with a volume of 175.94K.
It is up +1.55% in the last 24 hours and up +1.01% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$313.64
Open:
$314.1
24h Volume:
175.94K
Relative Volume:
0.28
Market Cap:
$25.83B
Revenue:
$14.14B
Net Income/Loss:
$942.70M
P/E Ratio:
28.22
EPS:
11.2856
Net Cash Flow:
$1.38B
1W Performance:
+2.09%
1M Performance:
+1.01%
6M Performance:
+18.46%
1Y Performance:
+13.84%
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LH
Labcorp Holdings Inc
|
318.49 | 25.83B | 14.14B | 942.70M | 1.38B | 11.29 |
|
TMO
Thermo Fisher Scientific Inc
|
674.47 | 249.38B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
225.41 | 158.46B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
400.58 | 57.74B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
172.70 | 48.69B | 7.23B | 1.41B | 1.09B | 4.979 |
|
IQV
Iqvia Holdings Inc
|
262.99 | 43.29B | 16.63B | 1.39B | 2.12B | 8.0674 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Global Decentralized Clinical Trials Market Size, Trends, and Forecast, 2025-2030 | AI, Wearables, and Cloud-Based Platforms Fuel 13.7% CAGR to $18.8 Billion - GlobeNewswire Inc.
Labcorp (NYSE:LH) Stock Price Breaks Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Labcorp Holdings Inc. (LH) Options Chain - Yahoo! Finance Canada
What to Expect From Labcorp Holdings’ Q3 2026 Earnings Report - Yahoo Finance
Here's Why Labcorp Holdings (LH) is a Strong Value Stock - Zacks Investment Research
Labcorp Holdings Inc. (N6B.DE) analyst ratings, estimates and forecasts - Yahoo Finance Australia
Labcorp Holdings Inc. (N6B.DE) insider ownership and holdings - Yahoo Finance UK
Labcorp Holdings Inc. (N6B.DE) Analyst Ratings, Estimates & Forecasts - Yahoo! Finance Canada
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Holdings Inc. (N6B.DE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Labcorp Holdings Inc. (N6B.DE) Stock Forum & Discussion - Yahoo! Finance Canada
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Labcorp stock after-hours at EUR 273.00: plus 0.74 percent versus Lang & Schwarz prior close - AD HOC NEWS
Truist raises target for Labcorp stock to USD 365.00 - AD HOC NEWS
Labcorp, the company behind Labcorp stock, sets results date - AD HOC NEWS
Labcorp Holdings Inc. (NYSE:LH) Stock Has Average Price Target of $337.73 According to Brokerages - MarketBeat
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace? - Zacks Investment Research
Labcorp to report Q3 2026 results Oct. 28, will webcast earnings at 9:00 a.m. ET - TradingView
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026 - Morningstar
A 9 a.m. ET webcast will discuss Labcorp's third-quarter results on Oct. 28. - Stock Titan
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026 - Moomoo
Fortrea Beats Investor Suit Over Labcorp Spinoff Woes - Law360
Is This the Right Time to Add Labcorp Stock to Your Portfolio? - Zacks Investment Research
Is This the Right Time to Add Labcorp Stock to Your Portfolio? - Yahoo Finance
Is This the Right Time to Add Labcorp Stock to Your Portfolio? - TradingView
GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Labcorp Holdings Inc. R (N6B.DE) Q1 FY2026 earnings call transcript - Yahoo Finance
Labcorp Holdings Inc. R (N6B.DE) Q4 FY2025 earnings call transcript - Yahoo Finance
Labcorp Holdings Inc. (N6B.DE) balance sheet - uk.finance.yahoo.com
N6B.DE Interactive Stock Chart | Labcorp Holdings Inc. R Stock - Yahoo Finance
Labcorp Holdings Inc. (N6B.DE) stock historical prices and data - uk.finance.yahoo.com
Labcorp Holdings Inc. (N6B.DE) Insider Ownership & Holdings - Yahoo! Finance Canada
Labcorp Holdings Inc. (N6B.DE) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
Labcorp Holdings Inc. (N6B.DE) Options ChainYahoo Finance - Yahoo! Finance Canada
Global Paternity & Relationship Testing Services Market Set for Growth Through 2030 as DNA Testing Demand Expands Across Applications and Product Segments - GlobeNewswire Inc.
Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day - Yahoo Finance
Why Labcorp Holdings Stock Dropped Today - The Motley Fool
Is Labcorp Holdings Stock Outperforming the Dow? - Yahoo Finance
Why Labcorp Holdings Stock Dropped Today - Yahoo Finance
Why Labcorp Holdings Stock Dropped Today - The Motley Fool
Rare Disease Contract Research Organization (CRO) Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook - GlobeNewswire Inc.
Labcorp Holdings Inc. $LH Shares Purchased by Tidal Investments LLC - MarketBeat
National Pension Service Sells 146,486 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. (LH) Analyst/Investor DaySlideshow (NYSE:LH) 2026-09-12 - Seeking Alpha
Labcorp stock falls after Investor Day and holds guidance - ad-hoc-news.de
UBS Adjusts Labcorp Price Target to $380 From $361, Maintains Buy Rating - marketscreener.com
Rep. April McClain Delaney Sells Off Labcorp Holdings Inc. (NYSE:LH) Shares - MarketBeat
Rep. April McClain Delaney Sells Labcorp Holdings Inc. (NYSE:LH) Stock - MarketBeat
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Labcorp Holdings Inc Stock (LH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| KERRII B ANDERSON | Director |
Aug 17 '26 |
Proposed Sale |
318.13 |
3,000 |
954,390 |
0 |
| Schechter Adam H | Officer |
Aug 11 '26 |
Proposed Sale |
320.37 |
4,669 |
1,495,808 |
0 |
| Schechter Adam H | President & CEO |
Aug 11 '26 |
Sale |
320.37 |
4,669 |
1,495,808 |
102,565 |
| Summy Amy B. | EVP, Chief Marketing Officer |
Aug 04 '26 |
Sale |
306.74 |
924 |
283,428 |
6,956 |
| Summy Amy B. | Officer |
Aug 04 '26 |
Proposed Sale |
306.74 |
924 |
283,428 |
0 |
| Wilkinson Peter J | SVP, Chief Accounting Officer |
Aug 03 '26 |
Sale |
309.23 |
1,420 |
439,107 |
1,770 |
| Wilkinson Peter J | SVP, Chief Accounting Officer |
Aug 03 '26 |
Option Exercise |
209.25 |
1,338 |
279,976 |
3,108 |
| Vaughn Bryan T | EVP and President, Diagnostics |
Jul 02 '26 |
Sale |
286.19 |
234 |
66,968 |
6,746 |
| Kyle Kathryn W | EVP, Chief Legal Officer |
Jul 02 '26 |
Sale |
286.19 |
92 |
26,329 |
3,904 |
| Kyle Kathryn W | Officer |
Jul 02 '26 |
Proposed Sale |
286.19 |
92 |
26,329 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):